Evidence map›Paper›PMID 28204911›Full record

ArticlePlant cell reports2017

Selection of transformation-efficient barley genotypes based on TFA (transformation amenability) haplotype and higher resolution mapping of the TFA loci.

Hiroshi Hisano, Brigid Meints, Matthew J Moscou, Luis Cistue, Begoña Echávarri, Kazuhiro Sato, Patrick M Hayes

Abstract read
PubMed Publisher
In one paragraph

Article in Plant cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Rapid development of naked malting barley germplasm through targeted mutagenesis.Molecular breeding : new strategies in plant improvement · 2025
    Article
  3. Article
  4. Article
  5. Targeted Modification of Grain Dormancy Genes in Barley.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Frontiers in plant science · 2020
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hiroshi HisanoInstitute of Plant Science and Resources, Okayama University, 2-20-1 Chuo, Kurashiki, Japan. hiroshi.hisano@rib.okayama-u.ac.jp.ORCID http://orcid.org/0000-0001-8457-253X
Brigid MeintsDepartment Crop and Soil Sciences, Washington State University, Mount Vernon, WA, USA.
Matthew J MoscouThe Sainsbury Laboratory, Norwich Research Park, Norwich, UK.
Luis CistueDepartment Genetica y Produccion Vegetal, Estacion Experimental de Aula Dei, Zaragoza, Spain.
Begoña EchávarriDepartment Genetica y Produccion Vegetal, Estacion Experimental de Aula Dei, Zaragoza, Spain.
Kazuhiro SatoInstitute of Plant Science and Resources, Okayama University, 2-20-1 Chuo, Kurashiki, Japan.
Patrick M HayesDepartment Crop and Soil Science, Oregon State University, Corvallis, OR, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

key messageThe genetic substitution of transformation amenability alleles from 'Golden Promise' can facilitate the development of transformation-efficient lines from recalcitrant barley cultivars. Barley (Hordeum vulgare) cv. 'Golden Promise' is one of the most useful and well-studied cultivars for genetic manipulation. In a previous report, we identified several transformation amenability (TFA) loci responsible for Agrobacterium-mediated transformation using the F

Indexed as

Agrobacterium tumefaciensChromosome MappingGenotypeHaploidyHaplotypesHordeumPlant ProteinsSeedsTransformation, GeneticPlant ProteinsAgrobacterium tumefaciensDoubled haploidHordeum vulgare (barley)Single nucleotide polymorphismTransformation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.